About

About UNIVO IRB Univo IRB is the only mid-size central institutional review board (IRB) specializing in the next generation of human research protection. Led by industry experts and powered by new IRB platformtechnology, we are committed to advancing the standards of research ethics and partnering with companies to protect patients designed for today. Operating as a full service central and single IRB of record, Univo has extensive experience in Phase I-IV pharmaceutical, device, biologic, behavioral, and psycho-social research. •Univo’s forward thinking approach over the last year has gained the reputation as the new modern IRB with deep understanding of human research and advancements in research around decentralized methodologies and AI. With our nimble and tailored solutions we can fit into the context of your program, while holding the highest respect for all individuals, ensuring that we never harm and always protect the welfare of everyone involved. We go beyond the bare minimum to unite research participants with researchers, striving to provide universal access to research opportunities and its benefits. Our core focus is on the participant, with their voice at the heart of every decision we make. Univo IRB is an independent, technology-enabled Institutional Review Board delivering fast, friendly, and fair ethical review for human-participant research. We simplify the IRB process through our proprietary platform, OneVerse®, which streamlines submissions, communication, and document management—allowing research teams to focus more on participants and progress, not paperwork. Our experienced board and responsive staff understand the daily realities of clinical research and are committed to providing clear guidance, timely reviews, and reliable support at every stage. Whether you’re managing a single-site study or a multi-site clinical trial, Univo IRB partners with you to ensure compliance, protect participants, and help move science forward with confidence.